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The NLRP3 inflammasome plays a major role in
innate immune responses by activating caspase-1,
resulting in secretion of interleukin-18 (IL-18) and
IL-1b. Although cytosolic double-stranded RNA
(dsRNA) and bacterial RNA are known to activate
the NLRP3 inflammasome, the upstream sensor is
unknown. We investigated the potential function of
DExD/H-box RNA helicase family members (previ-
ously shown to sense cytosolic DNA and RNA to
induce type 1 interferon responses) in RNA-induced
NLRP3 inflammasome activation. Among the heli-
case family members tested, we found that targeting
of DHX33 expression by short hairpin RNA efficiently
blocked the activation of caspase-1 and secretion of
IL-18 and IL-1b in human macrophages that were
activated by cytosolic poly I:C, reoviral RNA, or
bacterial RNA. DHX33 bound dsRNA via the heli-
case C domain. DHX33 interacted with NLRP3 and
formed the inflammasome complex following stimu-
lation with RNA. We therefore identified DHX33 as
a cytosolic RNA sensor that activates the NLRP3
inflammasome.
INTRODUCTION
Recognition of cytosolic viral nucleic acids by specific pathogen
recognition receptors (PRRs) is critical for the innate immune
system to detect viral infection and mount antiviral type 1 inter-
feron (IFN) and inflammatory responses (Wilkins and Gale,
2010). During the past decade, four classes of sensors have
been identified that sense cytosolic viral DNA and RNA and acti-
vate type-1 IFN responses: the DExD/H-box helicase family
members RIG-I, MDA-5, LGP-2, DDX1, DDX41, DDX60, DHX9,
DHX36 (Kato et al., 2006; Kim et al., 2010; Miyashita et al.,
2011; Satoh et al., 2010; Yoneyama et al., 2004; Zhang et al.,
2011b, 2011c, 2011d); IFI16 (a pyrin and HIN domain-containing
protein) (Unterholzner et al., 2010); IFIT1 (interferon-induced
protein with tetratricopeptide repeats 1) (Pichlmair et al., 2011);
and LRRFIP1 (leucine-rich repeat flightless-interacting protein 1)
(Yang et al., 2010). AIM2 (IFN-inducible absent in melanoma 2)was identified as a cytosolic DNA sensor that activates the
ASC-containing inflammasome and triggers caspase-1-depen-
dent interleukin-1b (IL-1b) production (Bu¨rckstu¨mmer et al.,
2009; Fernandes-Alnemri et al., 2009; Hornung et al., 2009; Rob-
erts et al., 2009). Although cytosolic synthetic double-stranded
RNA (dsRNA), poly I:C (Kanneganti et al., 2006a; Rajan et al.,
2010; Rintahaka et al., 2008), virus-derived dsRNA (Kanneganti
et al., 2006a), and bacteria-derived RNA (Eigenbrod et al.,
2012; Kanneganti et al., 2006b; Sander et al., 2011) were found
to activate the NLRP3 inflammasome independently of known
cytosolic RNA sensors, the upstream RNA sensors that activate
the NLRP3 inflammasome have not been identified.
Inflammasomes are cytosolic multiprotein complexes that
activate caspase-1. Activated caspase-1 processes pro- IL-18
and pro-IL-1b to their biologically mature secreted forms.
IL-18 and IL-1b are pleiotropic proinflammatory cytokines and
play pivotal roles in regulating innate immune responses in addi-
tion to instructing adaptive immune responses. The NLRP3 (also
called cryopyrin, CIAS1, or NALP3) inflammasome recognizes
various kinds of exogenous and endogenous danger signals.
Once NLRP3 is activated by cytosolic stimuli, it starts to
oligomerize and recruit the adaptor protein ASC (also called
PYCARD), resulting in the cleavage of pro-caspase-1 to the
active form of caspase-1 (Schroder and Tschopp, 2010).
Recently, several groups reported an important role of mito-
chondria in NLRP3 inflammasome activation (Nakahira et al.,
2011; Shimada et al., 2012; Zhou et al., 2011). Thioredoxin-
interacting protein (TXNIP) was identified as an NLRP3-binding
partner that triggers activation of the NLRP3 inflammasome in a
mitochondrial reactive oxygen species (ROS)-sensitive manner
by stimulation with monosodium urate crystals (MSU), R837,
H2O2, and nigericin (Zhou et al., 2010, 2011). The NLRP3
inflammasome can recognize diverse stimuli via the common
mechanisms of mitochondrial damage. However, cytosolic
nucleic acids do not induce mitochondrial depolarization (Shi-
mada et al., 2012) and should be recognized specifically to
distinguish non-self-pathogens from self. Thus, a cytosolic
RNA sensor could act upstream of NLRP3 and interact with
NLRP3 to initiate NLRP3 oligomerization, followed by recruit-
ment of ASC.
Our laboratory has recently identified several members of the
DExD/H-box helicase family as DNA and RNA sensors that
induce type 1 IFN responses in dendritic cells (DCs) (Kim
et al., 2010; Zhang et al., 2011b, 2011c, 2011d). We decided
to systematically screen the 59 members of the DExD/H-boxImmunity 39, 123–135, July 25, 2013 ª2013 Elsevier Inc. 123
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induced NLRP3 inflammasome activation. Here, we demon-
strate that DHX33, a member of DExD/H-box helicase family,
sensed cytosolic RNA and formed a complex with NLRP3
and ASC in human macrophages, resulting in the cleavage of
caspase-1 and secretion of IL-18 and IL-1b. DHX33 as a cyto-
solic RNA sensor that trigger inflammasome activation may
shed new light on infection-induced pathology, and these find-
ings may provide important information for infection-induced
inflammatory diseases and self-RNA-induced autoimmune
diseases.
RESULTS
Targeting of DHX33 Expression Abolishes the Activation
of the NLRP3 Inflammasome via Cytosolic Poly I:C
We first performed coimmunoprecipitation experiments in
HEK293T cells overexpressing NLRP3 and one of helicases to
determine whether any of the 59 members of the DExD/H heli-
case family could bind NLRP3. We found that DDX11, DHX29,
DHX32, DHX33, DHX40, and DDX41 bound NLRP3 in this assay
(see Figure S1A available online). We then efficiently targeted
the expression of each helicase mentioned above by short
hairpin RNA (shRNA) in human THP-1 macrophages and
screened for poly I:C-induced inflammasome activation. Pro-
IL-18 was constitutively expressed before and after stimulation
with poly I:C in THP-1 macrophages (Figure S1B), indicating
that secretion of IL-18 depends on only inflammasome activa-
tion. We therefore analyzed IL-18 secretion by ELISA in the
functional screening for the inflammasome activation. Among
all potential NLRP3-binding helicases tested, we found that
targeting of DHX33 expression led to the most substantial
reduction in IL-18 secretion in THP-1 macrophages that were
stimulated with poly I:C (Figure S1C). We therefore decided to
focus on DHX33. We developed two distinct DHX33-targeting
shRNA constructs that most efficiently targeted DHX33 expres-
sion without affecting expression of NLRP3, ASC, caspase-1, or
other NLRP3-binding helicases in THP-1 cells (Figures 1A
and 1B; Figure S1D). shRNAs specific for NLRP3, ASC, and
caspase-1 only downregulated the expression of the targeted
protein (Figure 1B). Targeting DHX33 expression led to a sub-
stantial reduction in the secretion of IL-18 and IL-1b (Figure 1C)
and the cleavage of caspase-1 (Figure 1D) that were induced by
cytosolic poly I:C in THP-1 macrophages. We next investigated
whether DHX33 was involved in other NLRP3 inflammasome
activation pathways. Targeting of DHX33 expression did
not block IL-18 and IL-1b secretion or cleavage of caspase-1
in THP-1 macrophages that were induced by nigericin and
LPS+ATP, the known NLRP3 inflammasome activators through
mitochondrial ROS (Figure 1E and 1F; Figure S1E and S1F) (Liao
et al., 2012; Zhou et al., 2011). Targeting of DHX33 expression
also did not block IL-18 secretion in THP-1 macrophages that
were induced by a ligand of TLR7/8 (R848), a known NLRP3 in-
flammasome activator through mitochondria/TXNIP (Figure 1G)
(Kanneganti et al., 2006b; Zhou et al., 2010). Similar experi-
ments were conducted with poly dA:dT to examine cytosolic
dsDNA-induced inflammasome activation. Targeting of DHX33
expression did not affect secretion of IL-18 induced by cytosolic
poly dA:dT (Figure 1H). Therefore, DHX33 is specifically124 Immunity 39, 123–135, July 25, 2013 ª2013 Elsevier Inc.involved in cytosolic dsRNA-induced NLRP3 inflammasome
activation.
Viral dsRNA and Bacterial RNA Activate NLRP3
Inflammasome
To further determine whether the presence of cytosolic dsRNA
initiated activation of the NLRP3 inflammasome, we stimulated
THP-1 macrophages with viral genomic dsRNA purified from
reovirus. We found that it induced secretion of IL-18 (Figure 2A)
and IL-1b (Figure 2B) and cleavage of caspase-1 (Figure 2C).
Pretreatment of reoviral genomic RNA with RNase V1, which
specifically degrades dsRNA, completely abolished the pro-
duction of IL-18 (Figure 2D), indicating that the inflammasome
activation in this system is mediated by dsRNA. In contrast to
poly I:C, cytosolic poly U, a synthetic single-stranded RNA
(ssRNA), did not induce inflammasome activation in THP-1
macrophages (Figures 2A–2C). In addition, as previously re-
ported in murine macrophages and dendritic cells (Eigenbrod
et al., 2012; Sander et al., 2011), cytosolic bacterial RNA from
Escherichia coli (E. coli) induced IL-18 secretion (Figure 2E),
IL-1b secretion (Figure 2F), and cleavage of caspase-1 (Fig-
ure 2G) in human THP-1 macrophages. Taken together, these
results indicate that cytosolic RNA derived from both of
virus and bacteria activate NLRP3 inflammasome in THP-1
macrophages.
DHX33 Is Required for NLRP3 Inflammasome Activation
Induced by Viral dsRNA and Bacterial RNA
We examined whether DHX33 is involved in the NLRP3 inflam-
masome activation that is mediated by reoviral RNA. Targeting
of DHX33, NLRP3, or caspase-1 expression led to a substantial
reduction in secretion of IL-18 and IL-1b (Figure 3A) or cleavage
of caspase-1 (Figure 3B) in THP-1 macrophages that were stim-
ulated with cytosolic reoviral RNA. Similarly, secretion of IL-18
and IL-1b (Figure 3C) or cleavage of caspase-1 (Figure 3D) that
were induced by bacterial RNA were abrogated by targeting of
DHX33 expression. We next examined the involvement of
DHX33 in inflammasome activation during live viral infection.
We infected THP-1 macrophages with respiratory syncytial virus
(RSV), which produces dsRNA during the replication process
(Martı´nez and Melero, 2002). Targeting of NLRP3 or DHX33
expression substantially reduced the secretion of IL-18 and
IL-1b (Figure 3E) or the cleavage of caspase-1 (Figure 3F) in
THP-1 macrophages infected with RSV. In addition, RSV titers
were higher in DHX33-gene targeting cells compared to
scramble control cells (Figure S2), suggesting that DHX33 may
play an important role in antiviral defense. Thus, we conclude
that DHX33 is critical for cytosolic RNA-induced inflammasome
activation in human THP-1 macrophages.
DHX33 Directly Interacts with Viral dsRNA via Its
Helicase C Domain
To determine whether DHX33 binds RNA, we performed copre-
cipitation experiments in which hemagglutinin (HA)-tagged
DHX33 (HA-DHX33), expressed and purified from HEK293T
cells, was incubated with biotinylated poly I:C or biotinylated
reoviral RNA, followed by precipitation with streptavidin beads.
We found that HA-DHX33 bound biotin-labeled poly I:C and
reoviral RNA (Figures 4A and 4B). With both dsRNA substrates,
Figure 1. Targeting of DHX33 Expression Abolishes Activation of the NLPR3 Inflammasome Induced by Cytosolic dsRNA
(A) DHX33 expression was analyzed by real-time PCR (left) and immunoblotting (IB) (right) in THP-1 cells that were naive and expressing either scrambled shRNA
(sh-scramble) or shRNA specific for DHX33 (sh-DHX33-1, sh-DHX33-2). GAPDH served as a loading control.
(B) NLRP3, ASC, and caspase-1 expression was analyzed by IB in THP-1 macrophages expressing sh-scramble or shRNA specific for NLRP3 (sh-NLRP3), ASC
(sh-ASC), caspase-1 (sh-caspase-1), or DHX33.
(C–F) THP-1macrophages expressing shRNAwere stimulated for 8 hr with 5 mg/ml poly I:C delivered to the cytosol via Lipofectamine 2000 (Lipo) (C and D) or with
2 mM nigericin (E and F). Culture supernatants were analyzed for IL-18 and IL-b by ELISA (C and E) and for cleaved caspase-1 by IB (D and F). Cell lysates were
analyzed by IB for pro-caspase-1 and GAPDH (D and F).
(G and H) IL-18 secretion was measured by ELISA in culture supernatants of THP-1 macrophages stimulated for 8 hr with 5 mg/ml R848 (G) or with 5 mg/ml poly
dA:dT plus Lipo (H).
Graph shows the mean ± SD of triplicate wells (**p < 0.001 versus scramble). Data are representative of three independent experiments. See also Figure S1.
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tion, the interaction of DHX33 with reoviral RNA was not
completely blocked by a high amount of unlabeled poly U (Fig-
ure 4B), indicating that DHX33 preferentially bind dsRNA, rather
than ssRNA. To exclude the possibility that HA-DHX33 protein
purified from HEK293T cells included other dsRNA-bindingproteins that mediated the interaction between DHX33 and
dsRNA, we repeated the coimmunoprecipitation experiments
by using histidine-tagged DHX33 (His-DHX33) that had been
generated in E. coli. His-DHX33 was precipitated by both poly
I:C and reoviral RNA, and binding was blocked by unlabeled
poly I:C (Figures 4C and 4D). Therefore, DHX33 directly bindsImmunity 39, 123–135, July 25, 2013 ª2013 Elsevier Inc. 125
Figure 2. Reoviral dsRNA and Bacterial RNA Activate Caspase-1 and Induce Secretion of IL-18 and IL-1b
(A–C) THP-1macrophages were stimulated for 8 hr with Lipo (control), poly U (1 or 5 mg/ml) plus Lipo, poly I:C (1 or 5 mg/ml) plus Lipo, or reoviral RNA (1 or 5 mg/ml)
plus Lipo. Culture supernatants were analyzed for IL-18 (A) and IL-b (B) by ELISA and for cleaved caspase-1 by immunoblotting (IB) (C). Cell lysates were analyzed
by IB for pro-caspase-1, pro-IL-1b, pro-IL-18, and GAPDH (C).
(D) THP-1 macrophages were stimulated for 8 hr with Lipo (control) or 5 mg/ml reoviral RNA plus Lipo pretreated without or with RNase A or RNase V1. Culture
supernatants were analyzed for IL-18 by ELISA.
(E–G) THP-1macrophageswere stimulated for 8 hr with Lipo or bacterial RNA from E. coli (1 or 5 mg/ml) plus Lipo. Culture supernatants were analyzed for IL-18 (E)
and IL-b (F) by ELISA and for cleaved caspase-1 by IB (G). Cell lysates were analyzed by IB for pro-caspase-1, pro-IL-1b, pro-IL-18, and GAPDH (G).
Graph shows the mean ± SD of triplicate wells (**p < 0.001 versus reoviral RNA without pretreatment).
Immunity
DHX33 Senses RNA and Activates NLRP3 Inflammasomespoly I:C and reoviral RNA. To map the regions of DHX33 that are
required for dsRNA-binding, we conducted immunoprecipita-
tion experiments with biotin-labeled poly I:C and truncated
forms of HA-DHX33 (Figure S3A). We found that the helicase
C (Helic-C) domain of DHX33 was required for binding to
poly I:C (Figure 4E). In addition, we performed coprecipitation
experiments by using HA-DHX33 from HEK293T cells and
biotinylated E. coli total RNA. E. coli RNA also pulled down
HA-DHX33, and the binding was blocked by unlabeled E. coli
RNA (Figure S3B).126 Immunity 39, 123–135, July 25, 2013 ª2013 Elsevier Inc.Reconstitution of shRNA-Resistant DHX33 Rescues
Inflammasome Activation in DHX33-Gene Targeting
Cells
To exclude the possibility of off-target effects of DHX33-shRNA,
we reconstituted DHX33 expression in DHX33-gene targeting
cells. Because the shRNA-targeting sequence was in the trans-
lated region, transfection of wild-type (WT) DHX33 could not
reconstitute DHX33 expression in DHX33-gene targeting cells
(Figures 5A and 5B). Therefore, an shRNA-resistant DHX33
(rDHX33) was generated by substitution of six nucleotides within
Figure 3. DHX33 Is Required for NLRP3 Inflammasome Activation Induced by Reoviral dsRNA, Bacterial RNA, and Live Virus
(A–F) THP-1macrophages expressing shRNAwere stimulated for 8 hr with 5 mg/ml reoviral RNAwith Lipo (A and B) or 5 mg/ml bacterial RNA from E. coli (C and D).
THP-1 macrophages expressing shRNA were infected for 16 hr with respiratory syncytial virus (RSV) (E and F). Culture supernatants were analyzed for IL-18 and
IL-b (A, C, E) by ELISA and for cleaved caspase-1 by immunoblotting (IB) (B, D, F). Cell lysates were analyzed by IB for pro-caspase-1 and GAPDH (B, D, F).
Graph shows the mean ± SD of triplicate wells. Data are representative of three independent experiments. See also Figure S2.
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sequence) (Figure 5A). In addition, we generated two forms of
rDHX33with either a deadNTPase domain that lacked ribosomal
RNA synthesis activity (K103N) (Zhang et al., 2011a) or with a
helic C domain (Dhelic C) deletion that lacks the ability to bind
dsRNA (Figure 5A). Transfection of these rDHX33 constructs
into DHX33-gene targeting cells could reconstitute DHX33
expression successfully (Figure 5B). Reconstitution of rDHX33
rescued the ability of DHX33-gene targeting cells to secret IL-
18 and IL-1b or to activate caspase-1 in THP1 macrophages
stimulated with dsRNA, indicating that DHX33-shRNA has no
off-target effects (Figures 5C and 5D). Reconstitution of
rDHX33 with the K103N mutation also rescued the ability of
DHX33-gene targeting cells to secret IL-18 and IL-1b or to acti-
vate caspase-1 in THP1 macrophages that were stimulated with
dsRNA. This indicates that the function of DHX33 in dsRNA-
induced inflammasome activation is independent of the ribo-
somal RNA (rRNA) synthesis function, which requires NTPase
domain (Figures 5C and 5D). However, reconstitution ofrDHX33 with the Dhelic C mutation failed to rescue
inflammasome activation induced by dsRNA, indicating that
dsRNA binding to the helic C domain is critical for inflammasome
activation (Figures 5C and 5D). Reconstitution of these rDHX33
in DHX33-gene targeting cells did not affect the inflammasome
activation induced by nigericin (Figures 5E and 5F).
DHX33 Binds NLRP3 via the DEAD Domain of DHX33
and the NACHT Domain of NLRP3
HEK293T cells were cotransfected with a vector encoding Myc-
NLRP3 plus a vector encoding HA-tagged helicases. Lysates of
transfected cells were immunoprecipitated with anti-HA anti-
body. We show the precipitation of DDX46, DDX54, DDX57,
RIG-I, MDA-5, LGP-2, Dicer, FANCM, and DHX33 in Figure 6A.
DHX33 pulled down NLRP3, but the other tested helicases
here, including cytosolic RNA sensors RIG-I and Mda-5 did
not. In addition, we showed that Myc-NLRP3 pulled down HA-
DHX33 (Figure S1A); thus, we confirmed the binding of DHX33
to NLRP3 in the HEK293T cells overexpression system. To seeImmunity 39, 123–135, July 25, 2013 ª2013 Elsevier Inc. 127
Figure 4. DHX33 Requires the Helicase C Domain for Binding to dsRNA
(A and B) HA-DHX33 was overexpressed in HEK293T cells and purified by anti-HA beads. Purified HA-DHX33 protein was incubated with biotinylated poly I:C (A)
or biotinylated genomic reoviral RNA (B) in the absence (0 mg) or presence (A, 5 or 50 mg of poly I:C; B, 50 mg of poly U, 5 or 50 mg of poly I:C) of unlabeled
competitor. Biotinylated poly I:C (A) or reoviral RNA (B) was precipitated by streptavidin beads, followed by immunoblotting (IB) for HA-DHX33.
(C and D) Recombinant His-DHX33, generated in E. coli, was incubated with biotinylated poly I:C (C) or biotinylated reoviral genomic RNA (D) in the absence (0 mg)
or presence (5 or 50 mg) of unlabeled poly I:C as a competitor. Biotinylated dsRNA was immunoprecipitated by streptavidin beads, followed by IB for DHX33.
(E) Purified full-length and truncated HA-DHX33 proteins were incubated individually with biotinylated poly I:C. Biotinylated poly I:C was immunoprecipitated by
streptavidin beads, followed by IB for HA-DHX33. DEAD, Asp-Glu-Ala-Asp domain; HELICc, helicase C-terminal domain; HA2, helicase-associated domain 2;
DUF, domain of unknown function.
See also Figure S3.
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tested the binding between DHX33 and other NLR (nucleotide-
binding domain and leucine-rich repeat containing) family pro-
teins NOD1 and NOD2. The binding affinities of NOD1 and
NOD2 to DHX33 were much weaker than that of NLRP3 to
DHX33 (Figure S4A). To determine whether DHX33 directly binds
NLRP3, we conducted immunoprecipitation experiments by
using a mixture of His-DHX33 and GST-NLRP3, each expressed
and purified from E. coli. We found that pull-down of recombi-
nant DHX33 coprecipitated recombinant NLRP3, indicating
that DHX33 directly binds NLRP3 (Figure 6B). To map the site
of DHX33 required for NLRP3-binding, we overexpressed full
length or truncated forms of HA-DHX33 with Myc-NLRP3 in
HEK293T cells, followed by precipitation with anti-HA beads.
We found that the Asp-Glu-Ala-Asp (DEAD) domain of DHX33
was required to interact with NLRP3 (Figure 6C). Likewise, we
generated truncated forms of Myc-NLRP3 (Figure S4B) and
expressed each of them in HEK293T cells along with HA-
DHX33 to identify the binding site of NLRP3 to DHX33 by coim-
munoprecipitation. We found that the NACHT domain of NLRP3
was required for NLRP3:DHX33 interaction (Figure 6D). Taken
together, these results indicate that DHX33 directly binds
NLRP3 through the DEAD domain of DHX33 and the NACHT
domain of NLRP3.128 Immunity 39, 123–135, July 25, 2013 ª2013 Elsevier Inc.DHX33 Forms the Inflammasome Complex with NLRP3
following Stimulation with Cytosolic RNA
We next investigated the presence of endogenous DHX33-
NLRP3-ASC complexes in THP-1 macrophages (that were
resting or stimulatedwith cytosolic poly I:C or nigericin) by immu-
noprecipitation with anti-DHX33 antibody. Although DHX33-
NLRP3-ASC complexes were undetectable in resting THP-1
macrophages, those complexes were detected following poly
I:C-stimulation (Figure 6E). This kinetics pattern was similar to
the interaction between TXNIP and NLRP3 (Zhou et al., 2010).
Alternatively, neither NLRP3 nor ASC were coprecipitated with
DHX33 after stimulation with nigericin (Figure 6E). To examine
whether DHX33 was able to bind ASC directly, we cotransfected
vectors encoding HA-DHX33 and either Myc-ASC or Myc-
NLRP3 into HEK293T cells that endogenously expressed neither
NLRP3 nor ASC. In the coimmunoprecipitation assay, ASC did
not bind to DHX33 (Figure 6F). In addition, an in vitro binding
assay with recombinant DHX33 and ASC protein generated in
E. coli did not show the interaction of these molecules (Fig-
ure S4C). Therefore, DHX33 may bind ASC indirectly through
NLRP3 in dsRNA-activated THP-1 macrophages. To charac-
terize the distribution of DHX33 in cellular compartments, we
analyzed its subcellular localization by confocal microscopy in
THP-1 monocytes and THP-1 macrophages that had been
Figure 5. Reconstitution of DHX33 in DHX33-Gene Targeting Cells Rescues Inflammasome Activation Induced by Cytosolic dsRNA
(A andB)The shRNA-resistantDHX33with6-nucleotide substitution in the21-mer targeting sequencewasconstructedwithout changingaminoacids (rDHX33).By
using this rDHX33 construct, we generated an NTPase deadmutant (rDHX33$K103N) and a helic C domain-deletedmutant (rDHX33$Dhelic C) (A). TheWTDHX33
(wtDHX33) and shRNA-resistant DHX33 constructs were transfected into DHX33-gene targeting THP-1 cells, followed by immunoblotting (IB) for DHX33 (B).
(C–F) Cells were stimulated for 8 hr with 5 mg/ml reoviral RNA plus Lipo (C and D) or 2 mMnigericin (E and F). Culture supernatants were analyzed for IL-18 and IL-b
by ELISA (C and E) and for cleaved caspase-1 by IB (D and F). Cell lysates were analyzed by IB for pro-caspase-1 and GAPDH (D and F).
Graph shows the mean ± SD of triplicate wells.
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detected mainly in the nucleus of THP-1 monocytes and
was diffusely distributed in both the nucleus and cytosol of
THP-1 macrophages (Figure S4D). We observed that NLRP3
redistributed from a diffused expression pattern (Figure 6Gb;
Figure S4Eb) into distinct spots after stimulation with both reovi-
ral RNA and nigericin (Figures 6Gf and 6Gj; Figure S4Ef and
S4Ej). Some bright DHX33 spots were observed in reoviral
RNA-stimulated cells (Figures 6Ge; Figure S4Ee), but not in ni-
gericin-stimulated cells (Figures 6Gi; Figure S4Ei). These
DHX33 bright spots were found to colocalize with NLRP3 spots
(Figures 6Gh; Figure S4Eh). Therefore, DHX33 mediates
inflammasome complex formation after stimulation with cyto-
solic RNA.DHX33 Is Involved in Cytosolic RNA-Induced NLRP3
Inflammasome Activation in Human Primary Monocyte-
Derived Macrophages
We next examined the role of DHX33 in human primary mono-
cyte-derived macrophages (MDM). We targeted DHX33 expres-
sion in MDM through the use of small interfering RNA (siRNA)
(Figure 7A) without affecting expression levels of the other
NLRP3-binding helicases (Figure S5A). Although DHX33 expres-
sion was not completely abolished, secretion of IL-18 (Figure 7B)
and IL-1b (Figure 7C) induced by reoviral RNA was significantly
reduced in DHX33-siRNA cells (p < 0.05). On the other hand,
IL-18 (Figure 7B) and IL-1b (Figure 7C) secretion induced by
nigericin was not altered in DHX33-gene targeting cells. In addi-
tion, the production of tumor necrosis factor-a (TNF-a) inducedImmunity 39, 123–135, July 25, 2013 ª2013 Elsevier Inc. 129
Figure 6. DHX33 Forms the Inflammasome Complex via Direct Binding to NLRP3
(A) HEK293T cells were cotransfected with a vector encoding Myc-NLRP3 plus a vector encoding an HA-DExD/H family member (DDX46, DDX54, DDX56,
DDX57, RIG-I, Mda-5, LGP-2, Dicer, FANCM, or DHX33) or a pCMV-HA empty vector (mock). HA-tagged helicases were immunoprecipitated, followed by
immunoblotting (IB) for Myc-NLRP3 and HA-helicases.
(B) A mixture of the purified GST-NLRP3 and His-DHX33 proteins generated in E. coli was immunoprecipitated with anti-DHX33 antibody or isotype control IgG,
followed by IB for NLRP3 and DHX33.
(C) HEK293T cells were cotransfected with a vector encoding Myc-NLRP3 along with a vector encoding a full-length or truncated HA-DHX33 (as in Figure S3A).
HA-tagged helicases were immunoprecipitated, followed by IB for HA-DHX33 and Myc-NLRP3.
(D) HEK293T cells were cotransfectedwith a vector encoding HA-DHX33 alongwith a vector encoding full-length or truncatedMyc-NLRP3 (as in Figure S4B). HA-
DHX33 was immunoprecipitated followed by IB for HA-DHX33 and Myc-NLRP3.
(legend continued on next page)
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Figure 7. DHX33 Is Involved in Cytosolic RNA-Induced NLRP3 Inflammasome Activation in Human Monocyte-Derived Macrophages
(A) DHX33 expression was analyzed by immunoblotting (IB) in human primary monocyte-derived macrophages (MDM) transfected with control siRNA (si-control)
or siRNA specific for DHX33 (si-DHX33-1, si-DHX33-2).
(B and C) MDM transfected with control siRNA or DHX33 siRNA were stimulated for 8 hr with 5 mg/ml reoviral RNA plus Lipo (left) or 2 mM nigericin (right). Culture
supernatants were analyzed for IL-18 (B) and IL-b (C) by ELISA.
(D) MDM were stimulated without (mock) or with poly I:C plus Lipo or nigericin for 2 hr. Immunoprecipitation was performed by anti-DHX33 antibody or isotype
control IgG, followed by IB for DHX33, NLRP3, ASC, and GAPDH.
Graph shows the mean ± SD of triplicate wells (*p < 0.05, **p < 0.01 versus scramble siRNA). See also Figure S5.
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(Figure S5B). We next examined the inflammasome complex
formation by immunoprecipitation in MDM. Pull down of
DHX33 coprecipitated NLRP and ASC in MDM stimulated with
reoviral RNA but not in resting cells or in nigericin-treated cells
(Figure 7D). Therefore, DHX33 is required for the activation of
the NLRP3 inflammasome induced by cytosolic RNA in human
primary MDM.
DISCUSSION
In this study, we have identified DHX33 as a sensor for viral
dsRNA that has the ability to directly bind NLRP3 and activate
the NLRP3-ASC inflammasome. This inflammasome mediates
caspase-1 cleavage and processing as well as secretion of
mature IL-18 and IL-1b. DHX33 bind dsRNA via the helicase C
domain. Following recognition of dsRNA, DHX33 interacted
with NLRP3 via the DEAD domain of DHX33 and the NACHT(E) THP-1 macrophages were stimulated for 0, 1, 2 and 4 hr with poly I:C plus Lip
isotype control IgG, followed by IB for DHX33, NLRP3, ASC, and GAPDH.
(F) HEK293T cells were cotransfected with a vector encoding HA-DHX33 along wi
Myc-ASC. Myc-tagged proteins were immunoprecipitated, followed by IB for My
(G) THP-1macrophages transfectedwith HA-DHX33were stimulated for 2 hr with
analyzed for the localization of HA-DHX33 (red) (a, e, i), NLRP3 (green) (b, f, j), nuc
See also Figure S4.domain of NLRP3, leading to the recruitment of ASC. This
DHX33:NLRP3 interaction at the protein level and clustered co-
localization within the cytosol could be induced only by dsRNA
stimulation, but not by another NLRP3 inflammasome activator,
nigericin. Together with the finding that shRNA-resistant DHX33
requires the presence of an intact dsRNA binding domain (the
helic C domain) to rescue inflammasome activation in DHX33-
gene targeting THP1 macrophages, these data indicate that
DHX33 is a specific dsRNA sensor for NLRP3 inflammasome
activation. A key question is whether shRNA for DHX33 has
any off-target effect that may be important for the NLRP3 inflam-
masome activation. Our reconstitution experiments with shRNA-
resistant DHX33 concluded that DHX33-shRNA used in our
study has no such off-target effect. Another important question
is whether the effect of DHX33 in dsRNA-induced NLRP3
inflammasome activation is due to the function of DHX33 in
rRNA synthesis (Zhang et al., 2011a). We performed reconstitu-
tion experiments with shRNA-resistant DHX33 that contained ao or nigericin. Immunoprecipitation was performed by anti-DHX33 antibody or
th a pCMV-Myc empty vector (Myc-mock) or a vector encoding Myc-NLRP3 or
c and HA-DHX33.
Lipo (mock) (a-d), reoviral RNA plus Lipo (reoviral RNA) (e–h) or nigericin (i–l) and
leus marker DAPI (blue) (c, g, k), and merge (d, h, l) with confocal microscopy.
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synthesis. These data demonstrated that NLRP3 inflammasome
activation in THP-1macrophages induced by cytosolic dsRNA is
independent of the NTPase domain. It is not uncommon that
most cytosolic DNA or RNA sensors, such as RIG-I, also have
multiple functions in cell proliferation, apoptosis, and develop-
ment (Besch et al., 2009; Jiang et al., 2011; Liu and Gu, 2011;
Zhang et al., 2008).
We therefore demonstrated that DHX33 represents a receptor
that links the pattern recognition of viral dsRNA to NLRP3 inflam-
masome activation. The DExD/H-box helicase superfamily has
at least 59 members. Previous studies have demonstrated that
members of this family including RIG-I, MDA-5, LGP-2, DDX1,
DDX41, DDX60, DHX9, and DHX36 play critical roles in sensing
viral DNA/RNA and triggering anti-viral type 1 IFN responses
(Kato et al., 2006; Kim et al., 2010; Miyashita et al., 2011; Satoh
et al., 2010; Yoneyama et al., 2004; Zhang et al., 2011b, 2011c,
2011d). Interestingly, different helicases appear to use different
signaling adaptor molecules for the activation of the type-1 IFN
pathway. For example, RIG-1, MDA-5, and DHX9, which recog-
nize dsRNA, use MAVS (IPS-1) (Kawai et al., 2005; Zhang et al.,
2011d); DDX1-DDX21-DHX36, which recognizes dsRNA, uses
TRIF (Zhang et al., 2011b); and DDX41, a dsDNA sensor, uses
STING (Zhang et al., 2011c) to activate the type-1 IFN pathway.
Here, we demonstrate that DHX33, a RNA sensor, uses NLRP3
to activate the secretion of proinflammatory cytokines. These
data suggest that the DExD/H-box helicase superfamily is highly
utilized by the innate immune system for detecting viral infection,
which activates different type 1 IFN pathways and the inflamma-
some pathway.
It has been suggested that members of NLR family, including
NAIP (NLR family, Apoptosis Inhibitory Protein), NOD1, NOD2,
NLRC4, NLRP1, and NLRP3, are cytosolic pattern recognition
receptors that link inflammatory responses to pathogen-associ-
ated molecular patterns (PAMPs) and host-derived molecular
patterns (danger-associated molecular patterns, DAMPs) (Bry-
ant and Fitzgerald, 2009; Franchi et al., 2009). However, it is still
not clear whether NLRs directly interact with PAMPs or DAMPs.
Our study suggests that NLRP3 functions as a signaling adaptor
rather than a sensor and is used by the RNA sensor DHX33 to
activate the inflammasome pathway. Two distinct bacterial pro-
teins, flagellin and PrgJ, have been shown to activate the NLRC4
inflammasome (Franchi et al., 2006;Miao et al., 2006, 2010). Kof-
oed et al. reported that NAIP5/6 and NAIP2, specifically recog-
nize flagellin and PrgJ, respectively. Then, NAIP5/6 and NAIP2
commonly bind to NLRC4 and forms inflammasome complexes
(Kofoed and Vance, 2011). Thus, DHX33 or NAIPs provide spec-
ificity for ligands and interact with adaptor NLRP3 or NLRC4,
triggering subsequent inflammasome activation.
Recent studies demonstrated that bacterial messenger RNA
could activate NLRP3 inflammasome (Kanneganti et al., 2006b;
Sander et al., 2011). We demonstrated in this study that
DHX33 also senses bacteria-derived RNA and is responsible
for NLRP3 inflammasome activation in human macrophages.
How DHX33 distinguishes viral/bacterial RNA from self-RNA
deserves further investigation.
Viral and bacterial infections trigger inflammasome activation
that contributes to infection-associated inflammatory diseases
and autoimmune diseases (Davis et al., 2011; Martinon et al.,132 Immunity 39, 123–135, July 25, 2013 ª2013 Elsevier Inc.2009; Shaw et al., 2011). The identification of AIM2 as a dsDNA
sensor and DHX33 as a dsRNA sensor that trigger inflamma-
some activation may shed new light on infection-induced
pathology. These findings may provide important information
for the development of new therapies for infection-induced
inflammatory diseases and self-DNA/RNA-induced autoim-
mune diseases.
EXPERIMENTAL PROCEDURES
Cell Culture
THP-1 cells, a human acute monocytic leukemia cell line, were maintained in
RPMI-1640 medium containing 10% (vol/vol) heat-inactivated fetal bovine
serum (FBS), 2mML-glutamine and 50 mM b-mercaptoethanol. HEK293T cells
and Vero cells were maintained in DMEM medium with 10% (vol/vol) heat-
inactivated FBS.
Isolation of Reoviral Genomic RNA
Vero cells were infected with reovirus serotype 3 (American Type Culture
Collection) at a multiplicity of infection of 0.1 PFU/cell. The supernatant was
collected when cells showed maximal cytopathic effect from viral infection,
centrifuged at 2,500 rpm for 30 min, and then passed through 0.45 mm filters.
The filtered supernatant was centrifuged at 21,000 rpm for 120 min. The viral
pellet was suspended in RLT Buffer (QIAGEN) and then RNA was extracted
with RNeasy kit with DNase I treatment (QIAGEN).
Plasmids
Complementary DNA (cDNA) encoding the open reading frames of DExD/
H-box RNA helicases, NLRP3, NOD1, NOD2, or ASC was subcloned into
pCMV-HA or pCMV-Myc vectors (Clontech). Based on pCMV-HA-full-length
DHX33 and pCMV-Myc-full-length NLRP3, truncated forms of the HA-DHX33
and Myc-NLRP3 genes were generated by inverse PCR methods with the
primers shown in Table S1. For reconstitution of DHX33, DHX33 cDNA was
subcloned into pCDH vector (System Biosciences). Based on pCDH-WT
DHX33 (wtDHX33), genes encoding shRNA-resistant DHX33 (rDHX33), an
NTPase domain-dead mutant (K103N), and the deletion mutant of Dhelic C
were generated by inverse PCR methods with the primers shown in Table S1.
Lentivirus Production and Infection
The targeting sequences of shRNAs for human DHX33, NLRP3, ASC, and cas-
pase-1 are the following (50 to 30); sh-DHX33-1: CATTTCCTTTAGAACCC
AAAT; sh-DHX33-2: GTTGACACGGGCATGGTTAAA; sh-NLRP3: GCGTTAGA
AACACTTCAAGAA; sh-ASC: CGGAAGCTCTTCAGTTTCACA; sh-caspase-1:
CTACAACTCAATGCAATCTTT. A PLKO.1 vector encoding shRNA for a
scrambled (Sigma) or a specific target molecule (Open Biosystems or Sigma)
was transfected into HEK293T cells together with psPAX2, a packaging
plasmid, and pMD2.G, an envelope plasmid, for producing viral particles
with Lipofectamine 2000 (Life Technologies). Similarly, pCDH vector encoding
wtDHX33, rDHX33, rDHX33$K103N, or rDHX33$Dhelic C was transfected into
HEK293T cells together with pPACKH1 Packaging Plasmid mix (System
Biosciences) with Lipofectamine 2000. Culture supernatants were harvested
24 hr and 48 hr after transfection and then centrifuged at 2,200 rpm for
15 min. THP-1 cells were infected with collected supernatants containing
lentiviral particles in the presence of 4 mg/ml polybrene (Sigma). After 48 hr
of culture, lentiviral-infected cells were selected by 5 mg/ml puromycin
(Invivogen). Gene targeting efficiency of each shRNA-targeted molecule and
expression level of reconstituted DHX33 were detected by real-time PCR
and/or immunoblot analysis.
Stimulation of THP-1 Macrophages
THP-1 cells were differentiated to macrophages with 60 nM phorbol 12-
myristate 13-acetate (PMA; Sigma) for 16 hr, and cells were cultured for an
additional 48 hr without PMA. Differentiated cells were stimulated for 8 hr in
96 well plates with 1.0 or 5.0 mg/ml poly I:C (Invivogen) plus Lipofectamine
2000, 1.0 or 5.0 mg/ml reoviral genomic RNA plus Lipofectamine 2000, 1.0 or
5.0 microgram/ml E. coli total RNA (Life Technologies) plus Lipofectamine
2000, 1.0 or 5.0 mg/ml poly U (Invivogen) plus Lipofectamine 2000, 5.0 mg/ml
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Cells were also stimulated with 1 ng/ml LPS for 8 hr, followed by treatment with
5mMATP for 2 hr. Culture supernatants were collected formeasurement of cy-
tokines and cleavage of caspase-1. Cells were harvested for real-time PCR or
immunoblot analysis.
Stimulation of Human Monocyte-Derived Macrophages
Buffy coats of blood samples from healthy donors were used for isolation
of peripheral blood monocytes. Monocytes were isolated with RosetteSep
Human Monocyte Enrichment Cocktail (STEMCELL Technologies) and were
differentiated into macrophages in RPMI-1640 medium containing 10%
(vol/vol) heat-inactivated fetal bovine serum (FBS), 2 mM L-glutamine, and
10 ng/ml M-CSF (Life Technologies) for 10 days. Control siRNA or DHX33
siRNA (Dharmacon) was transfected into macrophages with HiPerFect Trans-
fection Reagent (QIAGEN). The target sequences for DHX33 siRNA are as
follows: si-DHX33-1, CUACUAGAGUCUCAGAUGA; si-DHX33-2, CCAAAGG
GCUAUCGCAAAG. Forty-eight hours after siRNA transfection, cells were
stimulated for 8 hr in 96 well plates with 5.0 mg/ml reoviral RNA plus Lipofect-
amine 2000 or 2 mM nigericin.
Viral Infection
THP-1 macrophages were infected with RSV (B strain; Advanced Biotech-
nologies Inc) in Opti-MEM reduced-serum medium (Life Technologies).
Following adsorption for 2 hr at 37C, cells were washed with regular culture
medium and the infection was continued in regular culture medium for the indi-
cated time periods.
Enzyme-Linked Immunosorbent Assay (ELISA)
The concentrations of IL-18, IL-1b, and TNF-a in culture supernatants were
measured by ELISA kit (IL-18, MBL International; IL-1b, BD Biosciences;
TNF-a, R&D).
Immunoblot Analysis
Proteinswere probedwith a primary antibody as follows: polyclonal rabbit anti-
DHX33 (sc-137424; Santa Cruz), monoclonal mouse anti-NLRP3 (Cryo-2)
(ALX-804-881-C100; Enzo Life Sciences), monoclonal anti-ASC (D086-3;
MBL International), monoclonal rabbit anti-caspase-1 (D7F10) (3866; Cell
Signaling), monoclonal mouse anti-IL-1b (sc-52770; Santa Cruz), monoclonal
mouse anti-IL-18 (sc-13602; Santa Cruz), andmonoclonal mouse anti-GAPDH
(G9295; Sigma).
Expression and Purification of Recombinant Proteins
For the generation in a mammalian system, a PCMV-HA plasmid encoding
human DHX33 was transfected into HEK293T cells. The expressed HA-
DHX33 protein was purified by using the HA-tagged Protein Purification Kit
(MBL International). For the generation in a bacterial system, the cDNA
sequence encoding human DHX33 was subcloned into the pRSET vector
(Life Technologies) to encode a histidine (His) fusion. The plasmid was trans-
formed into E. coli BL21 (DE3) pLysS (Life Technologies), which was treated
with 0.5 mM isopropyl b-D-1-thiogalactopyranoside (IPTG). The His-DHX33
protein was then purified with HisTrap FF (GE Healthcare Life Sciences).
GST-tagged NLRP3 recombinant protein and GST-tagged ASC recombinant
protein generated in E. coli were obtained from Novus.
In Vitro RNA Binding Assay
Poly I:C, reoviral RNA, and E. coli total RNA were labeled with biotin with the
RNA 30 end Biotinylation Kit (Thermo Scientific). Purified DHX33 protein was
incubated with biotinylated RNA in the buffer (50 mM Tris, pH 7.5, 150 mM
NaCl, 0.3% [vol/vol] Nonidet-P40, 5 mM EDTA, and 10% [vol/vol] glycerol).
Biotin-labeled RNA was precipitated with High Capacity NeutrAvidin Agarose
(Thermo Scientific). For the confirmation of DHX33-binding specificity to RNA,
immunoprecipitation was done in the absence or presence of competitors
(unlabeled poly I:C, poly U, or E. coli total RNA).
Coimmunoprecipitation Assays with Transfected HEK293T Cells
pCMV vectors encoding Myc-tagged cDNA and HA-tagged cDNA were
cotransfected into HEK293T cells with Lipofectamine 2000. Cells were lysed
24 hr after transfection in the buffer (50 mM Tris, pH 7.5, 300 mM NaCl, 1%[vol/vol] Triton-X, 5mMEDTA, and 10% [vol/vol] glycerol). Lysates were immu-
noprecipitated by anti-HA agarose (Sigma) or by anti-Myc agarose (Sigma).
Coimmunoprecipitation Assays with Stimulated THP-1 Cells and
Monocyte-Derived Macrophages
THP-1cells (13107)weredifferentiatedwithPMA,and then treated for0, 1, 2, or
4 hr with 5.0 mg/ml poly I:C plus Lipofectamine 2000 or 2 mMnigericin. Similarly,
monocyte-derivedmacrophages were treated for 2 hr with or without 5.0 mg/ml
poly I:C plus Lipofectamine 2000 or 2 mMnigericin. Stimulated cells were resus-
pended in lysisbuffer (50mMTris, pH7.5, 150mMNaCl, 0.1%[vol/vol]Nonidet-
P40,5mMEDTA,and10%[vol/vol] glycerol). Lysateswere immunoprecipitated
with control rabbit immunoglobulin G (IgG) or anti-DHX33 antibody (NB100-
2581; Novus) with Protein-G Sepharose (Thermo Scientific).
Quantitative Real-Time PCR
RNA was isolated with the RNeasy Kit (QIAGEN) and used to synthesize cDNA
with the iScript cDNASynthesis Kit (Bio-Rad). iTaq SYBRGreen Supermix with
ROX (Bio-Rad) was used for quantitative PCR with the primers shown in Table
S2. RPL13A or GAPDH was used as a housekeeping control to normalize the
amounts of cDNA between each sample. The amount of the helicase cDNA
relative to the amount of RPL13A cDNA was measured as DCT = CT 3
RPL13A  CT 3 helicase. The ratio of helicase mRNA copies relative to
RPL13A mRNA copies was defined as 2DCT 3 K (K: constant).
Confocal Microscopy
THP-1 cells expressing HA-DHX33 were differentiated with PMA on coverslips
for 48 hr. Cells were stimulated with reoviral RNA plus Lipofectamine 2000,
2 mM nigericin, or Lipofectamine 2000 alone. Then the stimulated cells were
fixed with 4% paraformaldehyde and permeabilized with 0.1% saponin. After
blocking with 10% goat serum (Sigma), cells were incubated with monoclonal
mouse IgG1 anti-NLRP3 antibody (ALX-804-818-C100; Enzo Life Sciences)
overnight at 4C, followed by treatment with anti-mouse IgG1 antibody conju-
gated with Alexa Fluor 555 (A21127; Life Technologies). After blocking with
mouse IgG1 (eBioscience), cells were stained with Alexa Fluor 488-conjugated
monoclonal mouse anti-HA antibody (2350; Cell Signaling). Slides were
mounted with ProLongGold-DAPI mounting media (Life Technologies) and
were analyzed with a confocal microscope.
Statistical Analysis
Data were analyzed for statistical significance by two-tailed student’s t test or
Welch’s t test.
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